Houston Methodist ups TriNetX network with 1.3m patients

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/imaginima)
(Image: Getty/imaginima)

Related tags: TriNetX, Hospital, research network, Sanofi, Pfizer, Allergan, Clinical research, Clinical trial

Houston Methodist Hospital joins the TriNetX global health research network to provide RWD for study feasibility and academic collaboration in industry-sponsored clinical trials.

TriNetX’s research network includes member companies like Allergan​, Pfizer​, and Sanofi​, alongside multiple academic research institutes. Most recently, Tufts​ entered the network in April 2018 followed by University Hospitals​ in January 2019.

Houston Methodist, an academic and medical center, encompasses a translational research institute, and eight hospitals serving more than 1.3m patients. The hospital system also holds 1,960 credentialed researchers and 1,261 clinical protocols. 

Edward Jones, president and CEO of Houston Methodist Research Institute, said in a press release, “this membership allows us to broaden our participation in clinical trials for novel therapeutics that represent the prospect of hope to our patients.”

TriNetX’s research network currently spans 16 countries and thousands of clinical research sites representing over 300m patients.

Houston Methodist Hospital will gain access to the networks, which connects clinical researchers to patient populations in real-time. Additionally, it will have access to TriNetX’s analytic self-service offering added February 21, 2019 to simplify the analysis of real world data (RWD​).

Houston Methodist did not respond to our request for comment. 

Related news

Show more

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars